FI74951C - Foerfarande foer framstaellning av en monohydratiserad isoftalsyrapikolylamid i stabil kristallin form. - Google Patents

Foerfarande foer framstaellning av en monohydratiserad isoftalsyrapikolylamid i stabil kristallin form. Download PDF

Info

Publication number
FI74951C
FI74951C FI811257A FI811257A FI74951C FI 74951 C FI74951 C FI 74951C FI 811257 A FI811257 A FI 811257A FI 811257 A FI811257 A FI 811257A FI 74951 C FI74951 C FI 74951C
Authority
FI
Finland
Prior art keywords
picotamide
water
monohydrated
anhydrous
compound
Prior art date
Application number
FI811257A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI811257L (fi
FI74951B (fi
Inventor
Giovanni Orzalesi
Ivo Volpato
Original Assignee
Int Licensing & Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Licensing & Services filed Critical Int Licensing & Services
Publication of FI811257L publication Critical patent/FI811257L/fi
Application granted granted Critical
Publication of FI74951B publication Critical patent/FI74951B/fi
Publication of FI74951C publication Critical patent/FI74951C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40Acylated substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI811257A 1980-04-23 1981-04-22 Foerfarande foer framstaellning av en monohydratiserad isoftalsyrapikolylamid i stabil kristallin form. FI74951C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT48494/80A IT1143942B (it) 1980-04-23 1980-04-23 Picolilammide idrata di acido isoftalico ad azione antiaggregante piastrinica antitrombinica ed anticoagulante e procedimento per la sua preparazione
IT4849480 1980-04-23

Publications (3)

Publication Number Publication Date
FI811257L FI811257L (fi) 1981-10-24
FI74951B FI74951B (fi) 1987-12-31
FI74951C true FI74951C (fi) 1988-04-11

Family

ID=11266904

Family Applications (1)

Application Number Title Priority Date Filing Date
FI811257A FI74951C (fi) 1980-04-23 1981-04-22 Foerfarande foer framstaellning av en monohydratiserad isoftalsyrapikolylamid i stabil kristallin form.

Country Status (23)

Country Link
JP (1) JPS6043063B2 (it)
AT (1) AT375645B (it)
AU (1) AU537921B2 (it)
BE (1) BE888528A (it)
CA (1) CA1129419A (it)
CH (1) CH649533A5 (it)
DD (1) DD158397A5 (it)
DE (1) DE3113150C2 (it)
DK (1) DK155735C (it)
ES (1) ES501470A0 (it)
FI (1) FI74951C (it)
FR (1) FR2481283B1 (it)
GB (1) GB2080288B (it)
IE (1) IE51218B1 (it)
IL (1) IL62509A (it)
IT (1) IT1143942B (it)
NL (1) NL186860C (it)
NO (1) NO154193C (it)
NZ (1) NZ196677A (it)
OA (1) OA06795A (it)
PT (1) PT72899B (it)
SE (1) SE438674B (it)
ZA (1) ZA812362B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1214915B (it) * 1985-10-10 1990-01-31 Manetti & Roberts Italo Brit Derivato dell'acido 4-metossiisoftalico con attivita'farmacologica in disordini tromboembolici e procedimento per la sua preparazione
US5227492A (en) * 1988-01-20 1993-07-13 Yamanouchi Pharmaceutical Co., Ltd. Diurea derivatives useful as medicaments and processes for the preparation thereof
TW200900393A (en) * 2007-05-21 2009-01-01 Dybly Ag Salts of picotamide
CN111154113A (zh) * 2019-12-31 2020-05-15 肇庆学院 一种基于双核钴(ⅱ)的金属有机配合物及其制备方法
CN111154114A (zh) * 2019-12-31 2020-05-15 肇庆学院 一种基于5-乙氧基间苯二甲酸的锌(ⅱ)金属有机配位化合物及其制备方法
CN112159347B (zh) * 2020-10-27 2022-06-07 常州工程职业技术学院 吡考他胺的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL149810B (nl) * 1969-04-21 1976-06-15 Lilly Co Eli Werkwijze ter bereiding van een farmaceutisch preparaat door kristallijn cefalexine in een voor therapeutische toediening geschikte vorm te brengen, gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van voor bovengenoemde toepassing geschikt cefalexine.
IT1016005B (it) * 1970-07-01 1977-05-30 Manetti & Roberts Italo Brit Picolilamidi dell acido 4 idrossi isoftalico e suoi derivati e relativo procedimento di prepara zione
US3973026A (en) * 1975-02-05 1976-08-03 Societa Italo-Britannica L. Manetti-H. Roberts & C. Inhibitor of blood plate aggregation

Also Published As

Publication number Publication date
DK177281A (da) 1981-10-24
SE438674B (sv) 1985-04-29
ES8203086A1 (es) 1982-02-16
AU537921B2 (en) 1984-07-19
IE51218B1 (en) 1986-11-12
JPS5735566A (en) 1982-02-26
JPS6043063B2 (ja) 1985-09-26
AT375645B (de) 1984-08-27
FR2481283B1 (it) 1985-01-04
BE888528A (nl) 1981-08-17
NO811360L (no) 1981-10-26
PT72899A (en) 1981-05-01
ZA812362B (en) 1982-04-28
GB2080288A (en) 1982-02-03
DK155735C (da) 1989-10-02
NL8102016A (nl) 1981-11-16
OA06795A (fr) 1982-12-31
SE8101963L (sv) 1981-10-24
FR2481283A1 (it) 1981-10-30
CH649533A5 (it) 1985-05-31
PT72899B (en) 1982-04-05
IT1143942B (it) 1986-10-29
DK155735B (da) 1989-05-08
NL186860B (nl) 1990-10-16
ES501470A0 (es) 1982-02-16
NZ196677A (en) 1983-05-31
NO154193C (no) 1986-08-06
ATA166481A (de) 1984-01-15
DD158397A5 (de) 1983-01-12
IL62509A0 (en) 1981-05-20
DE3113150A1 (de) 1982-01-28
DE3113150C2 (de) 1985-05-15
CA1129419A (en) 1982-08-10
IE810808L (en) 1981-10-23
NL186860C (nl) 1991-03-18
IL62509A (en) 1984-03-30
IT8048494A0 (it) 1980-04-23
FI811257L (fi) 1981-10-24
AU6931081A (en) 1981-10-29
GB2080288B (en) 1984-02-01
NO154193B (no) 1986-04-28
FI74951B (fi) 1987-12-31

Similar Documents

Publication Publication Date Title
EP0340677B1 (en) Gabapentin monohydrate and a process for producing the same
KR960003615B1 (ko) 메틸 α-5(4,5,6,7-테트라하이드로(3,2-C)티에노 피리딜)(2-클로로페닐)-아세테이트의 우선성 광학이성체, 그 제법 및 그의 약제학적 조성물
KR100559283B1 (ko) Hiv 프로테아제 억제제의 비술페이트염
JP5086069B2 (ja) 重硫酸アタザナビルおよび新規形態の製造方法
KR100629825B1 (ko) EtO2C-CH2-(R)Cgl-Aze-Pab-OH의 결정질형태
JPH10101565A (ja) 胃腸血行障害を治療および予防するための医薬製剤を製造するためのベンズアゼピン−n−酢酸誘導体の使用
US4960931A (en) Gabapentin mohohydrate and a process for producing the same
JP2008514691A (ja) 薬学的に純粋な非晶質塩酸ドネペジルを製造するための精製されたマレイン酸ドネペジルの使用
FI74951C (fi) Foerfarande foer framstaellning av en monohydratiserad isoftalsyrapikolylamid i stabil kristallin form.
JPH07285990A (ja) ホウ素ペプチド誘導体、その製剤および治療的応用
KR20190052704A (ko) 결정질 형태
KR101852226B1 (ko) 오타믹사반의 벤조산염
EA001363B1 (ru) Кристаллический фармацевтический продукт
EP1409479B1 (en) 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazines and -piperidines as factor xa antagonists
JPH08225513A (ja) ナフトイルグアニジン誘導体
KR850000783B1 (ko) 모노하이드레이티드 이소프탈산 피콜릴아미드의 제조방법
US20220098186A1 (en) Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound
UA65631C2 (en) Bispiperidines as antithrombotic agents, a method for the preparation thereof and intermediate products
JPH02193971A (ja) トリ置換―2,3,4,5―テトラヒドロベンズアゼピン誘導体とその中間体
CN115515955A (zh) 4-[(7-氯-2-甲氧基苯并[b][1,5]萘啶-10-基)氨基]-2,6-双(吡咯烷-1-基甲基)苯酚及其盐的结晶形式
FR2771094A1 (fr) Derives de piperidine-2-carboxylate, leur preparation et leur application en therapeutique
KR20000068406A (ko) 결정질 제약 물질
WO2002014310A1 (fr) 2-[5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidyl]-n-[1-(2-[5-t-butyl-1,3,4-oxadiazolyl]carbonyl)-2-(r,s)-methylpropyl]acetamide chlorhydrate
EA008141B1 (ru) Способ получения малеата амлодипина

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: SANDOZ AG